These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2723594)

  • 1. Risks of overtreatment of hypertension.
    Aagaard GN
    J Fam Pract; 1989 Jun; 28(6):665-6. PubMed ID: 2723594
    [No Abstract]   [Full Text] [Related]  

  • 2. [Can low blood pressure also have risks? (interview by Dr. med. Jochen Aumiller)].
    Kolloch R
    MMW Fortschr Med; 2004 Apr; 146(16):18. PubMed ID: 15222495
    [No Abstract]   [Full Text] [Related]  

  • 3. ["Excessive" lowering of blood pressure. Are there diastolic blood pressure values which should not be breached?].
    Michel D
    Fortschr Med; 1991 Oct; 109(30):616. PubMed ID: 1761264
    [No Abstract]   [Full Text] [Related]  

  • 4. [Need for the treatment of mild hypertension].
    Eisenblätter D; Faulhaber HD
    Z Arztl Fortbild (Jena); 1985; 79(2):55-62. PubMed ID: 3922133
    [No Abstract]   [Full Text] [Related]  

  • 5. [Post-infarction arterial hypertension: more benefits or more risks of the antihypertensive treatment?].
    Avanzini F; Alli C
    G Ital Cardiol; 1997 Sep; 27(9):936-44. PubMed ID: 9378201
    [No Abstract]   [Full Text] [Related]  

  • 6. [Utilizing progress in modern antihypertensive therapy. Treating hypertension effectively from the beginning].
    MMW Fortschr Med; 2005 May; 147(19):48. PubMed ID: 15940938
    [No Abstract]   [Full Text] [Related]  

  • 7. [When and how much should blood pressure be lowered?].
    Distler A
    Internist (Berl); 1991 Mar; 32(3):144-9. PubMed ID: 2055685
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium channel blockers and myocardial infarction.
    Smith GN
    J Fam Pract; 1996 Jan; 42(1):30-2. PubMed ID: 8537801
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of hypertension in the aged].
    Distler A
    Verh Dtsch Ges Inn Med; 1990; 96():253-8. PubMed ID: 2151152
    [No Abstract]   [Full Text] [Related]  

  • 10. Mild hypertension.
    Hull DH
    Aviat Space Environ Med; 1985 Apr; 56(4):304-9. PubMed ID: 3888168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood pressure lowering and risk reduction under treatment with valsartan and its combination with hydrochlorothiazide (HCT)].
    Scholze J; Müller U
    MMW Fortschr Med; 2006 Oct; 148(42):48. PubMed ID: 17621800
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of older hypertensive patients.
    Hedner T; Kjeldsen S; Oparil S; Narkiewics K
    Blood Press; 2008; 17(4):184-5. PubMed ID: 18932064
    [No Abstract]   [Full Text] [Related]  

  • 13. The pressure's on. A hypertension drug taken by 28 million people is under scrutiny. What are the other options?
    Smith IK
    Time; 2000 Sep; 156(11):126. PubMed ID: 11067229
    [No Abstract]   [Full Text] [Related]  

  • 14. Relation of blood pressure response to therapy and the occurrence of myocardial infarction and stroke.
    Alderman MH; Madhavan S; Stanback ME; Davis TK
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S251-6. PubMed ID: 6177968
    [No Abstract]   [Full Text] [Related]  

  • 15. [Modern antihypertensive drug therapy].
    Spieker C; Barenbrock M; Rahn KH
    Fortschr Med; 1996 Nov; 114(32):425-30. PubMed ID: 9064265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypoperfusion syndrome (brain, heart) caused by antihypertensive agents].
    Satoh H; Noguchi M; Yasuda H
    Nihon Rinsho; 1992 May; 50 Suppl():131-4. PubMed ID: 1512948
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis and treatment of arterial hypertension in the elderly].
    Waeber B; Pechere A; Burnier M; Brunner HR
    Praxis (Bern 1994); 1996 Feb; 85(6):150-4. PubMed ID: 8701176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Target blood pressure values from the cardiologic viewpoint].
    Klein W
    Wien Med Wochenschr; 1999; 149(23-24):625-8. PubMed ID: 10721157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [7 causes of therapy refractory hypertension].
    Schumacher B
    MMW Fortschr Med; 2006 Mar; 148(13):6, 8. PubMed ID: 16642694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.